We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Axon Stock Rises 28.6% in a Month: Should Investors Buy or Wait?
Read MoreHide Full Article
Key Takeaways
Axon shares surged 28.6% in a month, far outpacing the industry.
AXON Connected Devices revenues rose 29.1%, Software & Services up 39.6%.
Axon forecasts 27-30% revenue growth for 2026 despite rising costs.
Shares of Axon Enterprise, Inc. (AXON - Free Report) have been showing impressive gains of late, rising 28.6% in the past month. Shares of the public safety technology solution provider have outpaced the Zacks sub-industry’s growth of 4.5% and the S&P 500 composite’s 3% decline. The company has also outperformed other industry players like Kratos Defense & Security Solutions, Inc. (KTOS - Free Report) and Leonardo DRS, Inc. (DRS - Free Report) , which have returned 5% and 25.2%, respectively, over the same time frame.
AXON Stock’s Price Performance
Image Source: Zacks Investment Research
Closing at $559.06 yesterday, the stock is trading below its 52-week high of $885.92 but significantly higher than its 52-week low of $396.41. Although the stock is hovering above its 50-day moving average, it is trading below its 200-day moving average.
AXON Shares’ 50-Day and 200-Day SMA
Image Source: Zacks Investment Research
Factors Favoring the Company
The strongest driver of Axon’s business at the moment is solid momentum in its Connected Devices segment. The company continues to witness growing popularity for its next-generation TASER 10 products, whose shipment began in 2023. Growth in cartridge revenues, driven by higher adoption of the TASER products, has been driving the segment’s performance. Solid demand for its next-generation body-worn camera, Axon Body 4, virtual reality training services and counter-drone equipment also supports its growth. Segmental revenues increased 29.1% year over year in 2025.
An increase in the aggregate number of users to the Axon network is aiding the Software & Services segment. Continued momentum in digital evidence management and increased demand for premium add-on features are driving the segment’s growth. Adoption of premium subscription plans also continues to rise as more customers recognize the value of enhanced capabilities. Revenues from the segment increased 39.6% in 2025.
The company remains focused on investing in newer areas within the software business, like AI products, real-time operations, drones and robotics, which bodes well for growth. Given the strength across its business, Axon provided bullish financial guidance. For 2026, the company expects revenues to increase in the range of 27-30% year over year.
The company’s strategic partnership with other companies enables it to expand its product offerings and customer base. In October 2025, Axon’s Dedrone business announced its partnership with TYTAN (a leading provider of interceptor systems for Group 3 drones) to boost detection, identification and mitigation capabilities of counter drone equipment. The integration of TYTAN’s kinetic interceptor technology enhances Dedrone’s CUAS mitigation capability, making it suitable to deploy against Group 3 threats.
Near-Term Concerns
The escalating costs and expenses are a concern for Axon’s bottom line. In 2025, the company’s cost of sales soared 33.3% year over year. The company incurred high costs and expenses related to business integration activities, an increase in headcount and higher wages and stock-based compensation expenses. Axon’s selling, general and administrative expenses also surged 39.8% year over year in 2025.
Axon has been facing the pressure of rising debt levels. Exiting the fourth quarter of 2025, the company’s long-term notes payable (net) were $1.73 billion. The same stood at zero at the end of 2024. This increase was primarily due to funds raised to support the company’s strategic investments, expansion activities and potential acquisitions.
Stretched Valuation
AXON’s lofty valuation remains a concern. The stock is trading at a forward 12-month price-to-earnings (P/E) ratio of 65.01X, higher than the industry average of 49.17X. This elevated valuation could make the stock vulnerable to further pullbacks if market sentiment sours.
While its peer, Leonardo DRS, is trading cheaper compared with AXON, Kratos Defense is trading at a premium. Notably, Leonardo DRS and Kratos Defense are trading at 36.85X and 111.68X, respectively.
Image Source: Zacks Investment Research
AXON’s Earnings Estimate Revision
The company’s earnings estimates for 2026 have increased 4.8% to $8.12 per share over the past 60 days. The figure indicates year-over-year growth of 18.5%.
Earnings estimates for 2027 have increased 15.4% to $10.67 per share. The figure also indicates year-over-year growth of 31.5%.
Image Source: Zacks Investment Research
Final Thoughts
Solid momentum across the Connected Devices and Software & Services segments, along with its investments in the AI space, drones and robotics, positions AXON favorably for impressive growth in the long run. However, a few challenges, such as escalating operating expenses, premium valuation and rising debt, are limiting this Zacks Rank #3 (Hold) company’s near-term prospects.
View the Zacks #1 Rank List
Image: Bigstock
Axon Stock Rises 28.6% in a Month: Should Investors Buy or Wait?
Key Takeaways
Shares of Axon Enterprise, Inc. (AXON - Free Report) have been showing impressive gains of late, rising 28.6% in the past month. Shares of the public safety technology solution provider have outpaced the Zacks sub-industry’s growth of 4.5% and the S&P 500 composite’s 3% decline. The company has also outperformed other industry players like Kratos Defense & Security Solutions, Inc. (KTOS - Free Report) and Leonardo DRS, Inc. (DRS - Free Report) , which have returned 5% and 25.2%, respectively, over the same time frame.
AXON Stock’s Price Performance
Image Source: Zacks Investment Research
Closing at $559.06 yesterday, the stock is trading below its 52-week high of $885.92 but significantly higher than its 52-week low of $396.41. Although the stock is hovering above its 50-day moving average, it is trading below its 200-day moving average.
AXON Shares’ 50-Day and 200-Day SMA
Image Source: Zacks Investment Research
Factors Favoring the Company
The strongest driver of Axon’s business at the moment is solid momentum in its Connected Devices segment. The company continues to witness growing popularity for its next-generation TASER 10 products, whose shipment began in 2023. Growth in cartridge revenues, driven by higher adoption of the TASER products, has been driving the segment’s performance. Solid demand for its next-generation body-worn camera, Axon Body 4, virtual reality training services and counter-drone equipment also supports its growth. Segmental revenues increased 29.1% year over year in 2025.
An increase in the aggregate number of users to the Axon network is aiding the Software & Services segment. Continued momentum in digital evidence management and increased demand for premium add-on features are driving the segment’s growth. Adoption of premium subscription plans also continues to rise as more customers recognize the value of enhanced capabilities. Revenues from the segment increased 39.6% in 2025.
The company remains focused on investing in newer areas within the software business, like AI products, real-time operations, drones and robotics, which bodes well for growth. Given the strength across its business, Axon provided bullish financial guidance. For 2026, the company expects revenues to increase in the range of 27-30% year over year.
The company’s strategic partnership with other companies enables it to expand its product offerings and customer base. In October 2025, Axon’s Dedrone business announced its partnership with TYTAN (a leading provider of interceptor systems for Group 3 drones) to boost detection, identification and mitigation capabilities of counter drone equipment. The integration of TYTAN’s kinetic interceptor technology enhances Dedrone’s CUAS mitigation capability, making it suitable to deploy against Group 3 threats.
Near-Term Concerns
The escalating costs and expenses are a concern for Axon’s bottom line. In 2025, the company’s cost of sales soared 33.3% year over year. The company incurred high costs and expenses related to business integration activities, an increase in headcount and higher wages and stock-based compensation expenses. Axon’s selling, general and administrative expenses also surged 39.8% year over year in 2025.
Axon has been facing the pressure of rising debt levels. Exiting the fourth quarter of 2025, the company’s long-term notes payable (net) were $1.73 billion. The same stood at zero at the end of 2024. This increase was primarily due to funds raised to support the company’s strategic investments, expansion activities and potential acquisitions.
Stretched Valuation
AXON’s lofty valuation remains a concern. The stock is trading at a forward 12-month price-to-earnings (P/E) ratio of 65.01X, higher than the industry average of 49.17X. This elevated valuation could make the stock vulnerable to further pullbacks if market sentiment sours.
While its peer, Leonardo DRS, is trading cheaper compared with AXON, Kratos Defense is trading at a premium. Notably, Leonardo DRS and Kratos Defense are trading at 36.85X and 111.68X, respectively.
Image Source: Zacks Investment Research
AXON’s Earnings Estimate Revision
The company’s earnings estimates for 2026 have increased 4.8% to $8.12 per share over the past 60 days. The figure indicates year-over-year growth of 18.5%.
Earnings estimates for 2027 have increased 15.4% to $10.67 per share. The figure also indicates year-over-year growth of 31.5%.
Image Source: Zacks Investment Research
Final Thoughts
Solid momentum across the Connected Devices and Software & Services segments, along with its investments in the AI space, drones and robotics, positions AXON favorably for impressive growth in the long run. However, a few challenges, such as escalating operating expenses, premium valuation and rising debt, are limiting this Zacks Rank #3 (Hold) company’s near-term prospects.
While current shareholders should hold their positions, new investors should wait for the stock to retract some of its recent gains and provide a better entry point. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.